# Rithm Property Trust Inc.: financial statements, quarterly

RPT · NYSE · CIK 1614806 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rpt.md) · [Financials](/companies/rpt/financials.md) · [Filings](/companies/rpt/filings.md) · [Insiders](/companies/rpt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rpt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.1](/filings/0001614806-24-000009.md) | [(16.3)](/filings/0001628280-24-007349.md) | [(49.4)](/filings/0001614806-25-000020.md) | [(9.0)](/filings/0001628280-24-034257.md) | [(2.8)](/filings/0001614806-24-000009.md) | [5.6 d](/filings/0001614806-25-000009.md) | [0.2](/filings/0001614806-25-000020.md) | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [14.8](/filings/0001628280-23-036487.md) | [14.5 d](/filings/0001628280-24-007349.md) | [14.1](/filings/0001628280-24-020313.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.1)](/filings/0001614806-24-000009.md) | [0.1 d](/filings/0001614806-25-000009.md) | [0.9](/filings/0001614806-25-000020.md) | [(0.8)](/filings/0001614806-25-000029.md) | [(0.0)](/filings/0001614806-25-000035.md) | [0.0 d](/filings/0001614806-26-000010.md) | [(0.1)](/filings/0001614806-26-000016.md) | [0.0](/filings/0001614806-26-000020.md) | [0.0](/filings/0001614806-25-000035.md) | [0.1 d](/filings/0001614806-26-000010.md) | [(0.0)](/filings/0001614806-26-000016.md) | [0.0](/filings/0001614806-26-000020.md) |
| Net income | $m | [(5.5)](/filings/0001614806-24-000009.md) | [(22.6) d](/filings/0001614806-25-000009.md) | [(74.0)](/filings/0001614806-25-000020.md) | [(12.7)](/filings/0001614806-25-000029.md) | [(8.0)](/filings/0001614806-25-000035.md) | [2.9 d](/filings/0001614806-26-000010.md) | [(3.4)](/filings/0001614806-26-000016.md) | [1.9](/filings/0001614806-26-000020.md) | [(0.3)](/filings/0001614806-25-000035.md) | [3.2 d](/filings/0001614806-26-000010.md) | [(2.0)](/filings/0001614806-26-000016.md) | [2.0](/filings/0001614806-26-000020.md) |
| Diluted EPS | $ per share | [(0.25)](/filings/0001614806-24-000009.md) | [(0.86)](/filings/0001628280-24-007349.md) | [(2.41)](/filings/0001614806-25-000020.md) | [(0.32)](/filings/0001614806-25-000029.md) | [(0.18)](/filings/0001614806-25-000035.md) | not reported | [(0.49)](/filings/0001614806-26-000016.md) | [0.08](/filings/0001614806-26-000020.md) | [(0.03)](/filings/0001614806-25-000035.md) | not reported | [(0.43)](/filings/0001614806-26-000016.md) | [0.09](/filings/0001614806-26-000020.md) |
| Basic EPS | $ per share | [(0.25)](/filings/0001614806-24-000009.md) | [(0.86)](/filings/0001628280-24-007349.md) | [(2.41)](/filings/0001614806-25-000020.md) | [(0.32)](/filings/0001614806-25-000029.md) | [(0.18)](/filings/0001614806-25-000035.md) | not reported | [(0.49)](/filings/0001614806-26-000016.md) | [0.08](/filings/0001614806-26-000020.md) | [(0.03)](/filings/0001614806-25-000035.md) | not reported | [(0.43)](/filings/0001614806-26-000016.md) | [0.09](/filings/0001614806-26-000020.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [63.9](/filings/0001628280-23-036487.md) | [52.8](/filings/0001614806-25-000009.md) | [100](/filings/0001628280-24-020313.md) | [72.0](/filings/0001628280-24-034257.md) | [84.0](/filings/0001614806-25-000035.md) | [64.3](/filings/0001614806-26-000010.md) | [97.4](/filings/0001614806-26-000016.md) | [98.6](/filings/0001614806-26-000020.md) | [81.4](/filings/0001614806-25-000035.md) | [79.3](/filings/0001614806-26-000020.md) | [96.3](/filings/0001614806-26-000016.md) | [66.7](/filings/0001614806-26-000020.md) |
| Total assets | $m | [1,375](/filings/0001628280-23-036487.md) | [1,336](/filings/0001614806-25-000009.md) | [1,244](/filings/0001628280-24-020313.md) | [912](/filings/0001628280-24-034257.md) | [858](/filings/0001614806-24-000009.md) | [977](/filings/0001614806-26-000010.md) | [1,028](/filings/0001614806-25-000020.md) | [1,014](/filings/0001614806-25-000029.md) | [1,003](/filings/0001614806-25-000035.md) | [1,042](/filings/0001614806-26-000020.md) | [931](/filings/0001614806-26-000016.md) | [929](/filings/0001614806-26-000020.md) |
| Total liabilities | $m | [1,052](/filings/0001628280-23-036487.md) | [1,025](/filings/0001614806-25-000009.md) | [988](/filings/0001628280-24-020313.md) | [657](/filings/0001628280-24-034257.md) | [611](/filings/0001614806-24-000009.md) | [731](/filings/0001614806-26-000010.md) | [732](/filings/0001614806-25-000020.md) | [720](/filings/0001614806-25-000029.md) | [712](/filings/0001614806-25-000035.md) | [750](/filings/0001614806-26-000020.md) | [644](/filings/0001614806-26-000016.md) | [644](/filings/0001614806-26-000020.md) |
| Shareholders' equity | $m | [320](/filings/0001628280-23-036487.md) | [309](/filings/0001614806-25-000009.md) | [254](/filings/0001628280-24-020313.md) | [254](/filings/0001628280-24-034257.md) | [246](/filings/0001614806-24-000009.md) | [247](/filings/0001614806-26-000010.md) | [296](/filings/0001614806-25-000020.md) | [295](/filings/0001614806-25-000029.md) | [292](/filings/0001614806-25-000035.md) | [292](/filings/0001614806-26-000020.md) | [287](/filings/0001614806-26-000016.md) | [285](/filings/0001614806-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.7) d](/filings/0001614806-24-000009.md) | [(12.1) d](/filings/0001614806-25-000009.md) | [(8.2)](/filings/0001614806-25-000020.md) | [16.2 d](/filings/0001614806-25-000029.md) | [(5.3) d](/filings/0001614806-25-000035.md) | [(2.4) d](/filings/0001614806-26-000010.md) | [(1.6)](/filings/0001614806-26-000016.md) | [(0.0) d](/filings/0001614806-26-000020.md) | [(5.8) d](/filings/0001614806-25-000035.md) | [(0.8) d](/filings/0001614806-26-000010.md) | [(3.0)](/filings/0001614806-26-000016.md) | [(1.0) d](/filings/0001614806-26-000020.md) |
| Capital expenditure | $m | not reported | [0.0 d](/filings/0001628280-24-007349.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.7](/filings/0001614806-26-000020.md) | [2.7](/filings/0001614806-26-000020.md) | [2.7](/filings/0001614806-26-000020.md) | [2.7](/filings/0001614806-26-000020.md) | [2.8](/filings/0001614806-26-000020.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-23-036487.md) | [0.0 d](/filings/0001628280-24-007349.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001614806-26-000016.md) | [0.0 d](/filings/0001614806-26-000020.md) | not reported | not reported | [0.2](/filings/0001614806-26-000016.md) | [0.0 d](/filings/0001614806-26-000020.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.8](/filings/0001628280-23-036487.md) | [22.9](/filings/0001628280-24-020313.md) | [23.6](/filings/0001628280-24-034257.md) | [24.2](/filings/0001614806-24-000009.md) | [30.9](/filings/0001614806-25-000020.md) | [39.3](/filings/0001614806-25-000029.md) | [45.3](/filings/0001614806-25-000035.md) | [7.6](/filings/0001614806-26-000016.md) | [7.6](/filings/0001614806-26-000020.md) | [45.4](/filings/0001614806-25-000035.md) | [7.6](/filings/0001614806-26-000016.md) | [7.7](/filings/0001614806-26-000020.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,772,564 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0001614806-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.